advertisement

Genetics

18 March 2010

DNA test may cut hospitalisations caused by blood thinner

A simple genetic test that helps doctors determine the best dose of the blood-thinner drug warfarin for individual patients could reduce hospitalizations by one-third during the early dose-adjustment phase, a new study has found.

This article has not necessarily been edited by Health24.

"Genetic testing is a tool clinicians can use to more accurately predict the best warfarin dose early on," Dr. Robert S. Epstein, chief medical officer and president of the Medco Research Institute in Franklin Lakes, N.J., said in a news release from the American College of Cardiology. "Patients may get to a stable dose more quickly and, therefore, have a lower risk of negative outcomes, such as excess bleeding or unwanted blood clotting."

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.